Pharmacokinetics and pharmacodynamics of butorphanol following intravenous administration to the horse

Heather K Knych, H. C. Casbeer, D. S. Mckemie, Rick Arthur

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Butorphanol is a narcotic analgesic commonly used in horses. Currently, any detectable concentration of butorphanol in biological samples collected from performance horses is considered a violation. The primary goal of the study reported here was to update the pharmacokinetics of butorphanol following intravenous administration, utilizing a highly sensitive liquid chromatography-mass spectrometry (LC-MS) assay that is currently employed in many drug-testing laboratories. An additional objective was to characterize behavioral and cardiac effects following administration of butorphanol. Ten exercised adult horses received a single intravenous dose of 0.1mg/kg butorphanol. Blood and urine samples were collected at time 0 and at various times for up to 120h and analyzed using LC-MS. Mean±SD systemic clearance, steady-state volume of distribution, and terminal elimination half-life were 11.5±2.5mL/min/kg, 1.4±0.3L/kg, and 5.9±1.5h, respectively. Butorphanol plasma concentrations were below the limit of detection (LOD) (0.01ng/mL) by 48h post administration. Urine butorphanol concentrations were below the LOD (0.05ng/mL) of the assay in seven of 10 horses by 120h post drug administration. Following administration, horses appeared excited as noted by an increase in heart rate and locomotion. Gastrointestinal sounds were markedly decreased for up to 24h.

Original languageEnglish (US)
Pages (from-to)21-30
Number of pages10
JournalJournal of Veterinary Pharmacology and Therapeutics
Volume36
Issue number1
DOIs
StatePublished - Feb 2013

Fingerprint

Butorphanol
butorphanol
pharmacology
intravenous injection
Intravenous Administration
pharmacokinetics
Horses
Pharmacokinetics
horses
Liquid Chromatography
liquid chromatography
Limit of Detection
Mass Spectrometry
detection limit
urine
Urine
mass spectrometry
drugs
Narcotics
narcotics

ASJC Scopus subject areas

  • Pharmacology
  • veterinary(all)

Cite this

Pharmacokinetics and pharmacodynamics of butorphanol following intravenous administration to the horse. / Knych, Heather K; Casbeer, H. C.; Mckemie, D. S.; Arthur, Rick.

In: Journal of Veterinary Pharmacology and Therapeutics, Vol. 36, No. 1, 02.2013, p. 21-30.

Research output: Contribution to journalArticle

@article{2d429d51865f47918e6b3e6e942edc37,
title = "Pharmacokinetics and pharmacodynamics of butorphanol following intravenous administration to the horse",
abstract = "Butorphanol is a narcotic analgesic commonly used in horses. Currently, any detectable concentration of butorphanol in biological samples collected from performance horses is considered a violation. The primary goal of the study reported here was to update the pharmacokinetics of butorphanol following intravenous administration, utilizing a highly sensitive liquid chromatography-mass spectrometry (LC-MS) assay that is currently employed in many drug-testing laboratories. An additional objective was to characterize behavioral and cardiac effects following administration of butorphanol. Ten exercised adult horses received a single intravenous dose of 0.1mg/kg butorphanol. Blood and urine samples were collected at time 0 and at various times for up to 120h and analyzed using LC-MS. Mean±SD systemic clearance, steady-state volume of distribution, and terminal elimination half-life were 11.5±2.5mL/min/kg, 1.4±0.3L/kg, and 5.9±1.5h, respectively. Butorphanol plasma concentrations were below the limit of detection (LOD) (0.01ng/mL) by 48h post administration. Urine butorphanol concentrations were below the LOD (0.05ng/mL) of the assay in seven of 10 horses by 120h post drug administration. Following administration, horses appeared excited as noted by an increase in heart rate and locomotion. Gastrointestinal sounds were markedly decreased for up to 24h.",
author = "Knych, {Heather K} and Casbeer, {H. C.} and Mckemie, {D. S.} and Rick Arthur",
year = "2013",
month = "2",
doi = "10.1111/j.1365-2885.2012.01385.x",
language = "English (US)",
volume = "36",
pages = "21--30",
journal = "Journal of Veterinary Pharmacology and Therapeutics",
issn = "0140-7783",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Pharmacokinetics and pharmacodynamics of butorphanol following intravenous administration to the horse

AU - Knych, Heather K

AU - Casbeer, H. C.

AU - Mckemie, D. S.

AU - Arthur, Rick

PY - 2013/2

Y1 - 2013/2

N2 - Butorphanol is a narcotic analgesic commonly used in horses. Currently, any detectable concentration of butorphanol in biological samples collected from performance horses is considered a violation. The primary goal of the study reported here was to update the pharmacokinetics of butorphanol following intravenous administration, utilizing a highly sensitive liquid chromatography-mass spectrometry (LC-MS) assay that is currently employed in many drug-testing laboratories. An additional objective was to characterize behavioral and cardiac effects following administration of butorphanol. Ten exercised adult horses received a single intravenous dose of 0.1mg/kg butorphanol. Blood and urine samples were collected at time 0 and at various times for up to 120h and analyzed using LC-MS. Mean±SD systemic clearance, steady-state volume of distribution, and terminal elimination half-life were 11.5±2.5mL/min/kg, 1.4±0.3L/kg, and 5.9±1.5h, respectively. Butorphanol plasma concentrations were below the limit of detection (LOD) (0.01ng/mL) by 48h post administration. Urine butorphanol concentrations were below the LOD (0.05ng/mL) of the assay in seven of 10 horses by 120h post drug administration. Following administration, horses appeared excited as noted by an increase in heart rate and locomotion. Gastrointestinal sounds were markedly decreased for up to 24h.

AB - Butorphanol is a narcotic analgesic commonly used in horses. Currently, any detectable concentration of butorphanol in biological samples collected from performance horses is considered a violation. The primary goal of the study reported here was to update the pharmacokinetics of butorphanol following intravenous administration, utilizing a highly sensitive liquid chromatography-mass spectrometry (LC-MS) assay that is currently employed in many drug-testing laboratories. An additional objective was to characterize behavioral and cardiac effects following administration of butorphanol. Ten exercised adult horses received a single intravenous dose of 0.1mg/kg butorphanol. Blood and urine samples were collected at time 0 and at various times for up to 120h and analyzed using LC-MS. Mean±SD systemic clearance, steady-state volume of distribution, and terminal elimination half-life were 11.5±2.5mL/min/kg, 1.4±0.3L/kg, and 5.9±1.5h, respectively. Butorphanol plasma concentrations were below the limit of detection (LOD) (0.01ng/mL) by 48h post administration. Urine butorphanol concentrations were below the LOD (0.05ng/mL) of the assay in seven of 10 horses by 120h post drug administration. Following administration, horses appeared excited as noted by an increase in heart rate and locomotion. Gastrointestinal sounds were markedly decreased for up to 24h.

UR - http://www.scopus.com/inward/record.url?scp=84872426099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872426099&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2885.2012.01385.x

DO - 10.1111/j.1365-2885.2012.01385.x

M3 - Article

C2 - 22339417

AN - SCOPUS:84872426099

VL - 36

SP - 21

EP - 30

JO - Journal of Veterinary Pharmacology and Therapeutics

JF - Journal of Veterinary Pharmacology and Therapeutics

SN - 0140-7783

IS - 1

ER -